Heterozygous and Homozygous JAK2V617F States Modeled by Induced Pluripotent Stem Cells from Myeloproliferative Neoplasm Patients
出版年份 2013 全文链接
标题
Heterozygous and Homozygous JAK2V617F States Modeled by Induced Pluripotent Stem Cells from Myeloproliferative Neoplasm Patients
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 9, Pages e74257
出版商
Public Library of Science (PLoS)
发表日期
2013-09-17
DOI
10.1371/journal.pone.0074257
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms
- (2013) Costanza Bogani et al. PLoS One
- Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples
- (2012) K. Kumano et al. BLOOD
- Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls
- (2012) S. Verstovsek et al. BLOOD
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- Trisomy Correction in Down Syndrome Induced Pluripotent Stem Cells
- (2012) Li B. Li et al. Cell Stem Cell
- Targeting JAK2 in the therapy of myeloproliferative neoplasms
- (2012) Mamatha M Reddy et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
- (2012) Oliver Weigert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- GermlineJAK2Mutation in a Family with Hereditary Thrombocytosis
- (2012) Adam J. Mead et al. NEW ENGLAND JOURNAL OF MEDICINE
- Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells
- (2012) G. A. MacLean et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- JAK2 the future: therapeutic strategies for JAK-dependent malignancies
- (2012) Lindsay M. LaFave et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis
- (2011) P. Guglielmelli et al. BLOOD
- New mutations and pathogenesis of myeloproliferative neoplasms
- (2011) W. Vainchenker et al. BLOOD
- Genome Sequencing of Mouse Induced Pluripotent Stem Cells Reveals Retroelement Stability and Infrequent DNA Rearrangement during Reprogramming
- (2011) Aaron R. Quinlan et al. Cell Stem Cell
- Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
- (2011) Animesh Pardanani et al. JOURNAL OF CLINICAL ONCOLOGY
- Somatic coding mutations in human induced pluripotent stem cells
- (2011) Athurva Gore et al. NATURE
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
- (2010) A. Quintas-Cardama et al. BLOOD
- Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling
- (2010) Edwin Chen et al. CANCER CELL
- Reprogramming of T Cells from Human Peripheral Blood
- (2010) Yuin-Han Loh et al. Cell Stem Cell
- Reprogramming of Human Peripheral Blood Cells to Induced Pluripotent Stem Cells
- (2010) Judith Staerk et al. Cell Stem Cell
- Generation of Induced Pluripotent Stem Cells from Human Terminally Differentiated Circulating T Cells
- (2010) Tomohisa Seki et al. Cell Stem Cell
- HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
- (2010) Sachie Marubayashi et al. JOURNAL OF CLINICAL INVESTIGATION
- Transient activation ofc-MYCexpression is critical for efficient platelet generation from human induced pluripotent stem cells
- (2010) Naoya Takayama et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Selective reduction of JAK2V617F-dependent cell growth by siRNA/shRNA and its reversal by cytokines
- (2009) A. Jedidi et al. BLOOD
- Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders
- (2009) Z. Ye et al. BLOOD
- Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells
- (2009) Y. Wang et al. BLOOD
- A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis
- (2009) O. Klimchenko et al. BLOOD
- Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors
- (2008) N. Takayama et al. BLOOD
- Improved Efficiency and Pace of Generating Induced Pluripotent Stem Cells from Human Adult and Fetal Fibroblasts
- (2008) Prashant Mali et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started